Vident Advisory’s Pfizer PFE Stock Holding History

Vident Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.29M	Buy	152,874 +16,879	+12%	+$449K	0.04%	395
2025 Q4	$3.39M	Buy	135,995 +39,539	+41%	+$997K	0.03%	422
2025 Q3	$2.46M	Buy	96,456 +25,464	+36%	+$629K	0.02%	506
2025 Q2	$1.72M	Sell	70,992 -9,422	-12%	-$220K	0.02%	547
2025 Q1	$2.04M	Buy	80,414 +71,082	+762%	+$1.86M	0.03%	478
2024 Q4	$248K	Buy	+9,332	New	+$253K	﹤0.01%	1245
2024 Q3	–	Sell	-95,822	Closed	-$2.68M	–	1518
2024 Q2	$2.68M	Buy	+95,822	New	+$2.64M	0.07%	281
2024 Q1	–	Sell	-55,541	Closed	-$1.6M	–	1381
2023 Q4	$1.6M	Sell	55,541 -3,952	-7%	-$119K	0.04%	431
2023 Q3	$1.97M	Buy	+59,493	New	+$2.1M	0.06%	312

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Vident Advisory's PFE Position: Q1 2026 in Review

Vident Advisory increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $449K and bringing the position to 152,874 shares worth $4.29M. The position accounts for 0.04% of the portfolio, ranked #395.

Vident Advisory first reported a position in PFE in Q3 2023 and has held it in 9 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Vident Advisory held 152,874 shares of Pfizer worth $4.29M as of Q1 2026.
Vident Advisory bought 16,879 Pfizer shares in Q1 2026, an estimated $449K.
Pfizer made up 0.04% of Vident Advisory's portfolio in Q1 2026, its #395 holding.
Vident Advisory first reported a position in Pfizer in Q3 2023 and has held it in 9 quarters since.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.